BioSpace News Archive

Three Medical Journals Investigate Temple University for Potential Data Manipulation

Three medical journals have launched investigations into publications by researchers at Temple University to determine if there was data manipulation.

September 14, 2022
·
4 min read
·
Mark Terry
Business

Bayer Seeks to Replace CEO Baumann in Shareholder Ouster

Bayer CEO Werner Baumann may be on the way out. For the past several years, Baumann has been in the sites of angry shareholders but has evaded an ouster. That soon may be over.

September 14, 2022
·
2 min read
·
Alex Keown
Business

Money on the Move: Sparing Vision, RayzeBio, Nimbus and More Garner Funds

This week was rife with Series financings, which channeled money into innovative treatments for immune diseases and cancers, genomic treatments and precision healthcare.

September 14, 2022
·
5 min read
·
Tristan Manalac
Drug Development

In Group of Firsts, ESMO Highlights Therapeutic Advances in Lung Cancer

NSCLC At ESMO: Pollution does indeed cause lung cancer; Tecentriq shows promise in poor prognosis patients, Amgen makes progress in KRAS G12-mutated disease and an update on a Daiichi Sankyo ADC.

September 14, 2022
·
6 min read
·
Gail Dutton
Drug Development

NASH Market Surges as Oramed, Akero Post Positive Data

Oramed announced positive mid-stage data that showed its investigational drug ORMD-0801 reduced liver fat content in type 2 diabetes patients who have been diagnosed with NASH.

September 14, 2022
·
3 min read
·
Alex Keown
Business

Capstan Therapeutics Launches with $165M for Precise in Vivo Cell Engineering

With $165 million in the bank, Capstan launched Wednesday to combine the potency of cell therapy with the precision of genetic medicines against various difficult-to-treat diseases.

September 14, 2022
·
2 min read
·
Tristan Manalac
Policy

Biden Issues Executive Order to Keep US Biotech Innovation Outpacing China

Biden issued an executive order to keep U.S.-based innovation ahead of advances made by counterparts in China biotechnology and biomanufacturing Monday.

September 14, 2022
·
2 min read
·
Alex Keown
Policy

Court Dismisses Whistleblower Lawsuit Against Novartis

A Manhattan court dismissed a whistleblower lawsuit against Novartis, which had alleged the company paid doctors to promote its multiple sclerosis drug Gilenya.

September 14, 2022
·
2 min read
·
Tristan Manalac
Orthopedic Medical Imaging Systems Market Growth Is Driven By Increasing Use Of Diagnostic Imaging Solutions For The Treatment Of Orthopedic Disorders In Hospitals

The growing geriatric population and rapid advancements in medical imaging technologies are other factors that could favor orthopedic medical imaging equipment market growth across the forecast period.

September 14, 2022
·
6 min read
Policy

Transcenta Received IND Clearance from FDA for Its First-In-Class Gremlin1 Targeting Antibody TST003 for the Treatment of Solid Tumors

Transcenta Holding Limited announces that TST003, its first-in-class, high affinity humanized monoclonal antibody targeting Gremlin1, has received IND clearance from U.S. Food and Drug Administration.

September 14, 2022
·
4 min read